111, Inc. balance sheet
At the end of fiscal 2025, 111, Inc. had total assets of $315m, total liabilities of $284m and shareholders' equity of −$100m. It held $73.1m in cash against $26.8m of debt: net cash of $46.2m.
Balance sheet
| Fiscal year | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 54 | 26 | 124 | 83 | 182 | 104 | 98 | 85 | 63 | 73 |
| Receivables | 4 | 3 | 4 | 9 | 25 | 63 | 71 | 76 | 57 | 37 |
| Inventory | — | 22 | 31 | 70 | 117 | 176 | 217 | 200 | 190 | 143 |
| Total current assets | — | 112 | 219 | 213 | 440 | 440 | 469 | 413 | 363 | 304 |
| Total assets | — | 117 | 234 | 231 | 464 | 494 | 504 | 435 | 382 | 315 |
| Accounts payable | — | 20 | 31 | 64 | 164 | 211 | 256 | 224 | 236 | 183 |
| Deferred revenue (current) | 1 | 2 | 2 | 9 | 18 | 28 | 43 | 18 | 21 | 16 |
| Total current liabilities | — | 31 | 46 | 111 | 250 | 334 | 395 | 387 | 321 | 279 |
| Short-term debt | — | — | — | 14 | 35 | 41 | 26 | 48 | 22 | 27 |
| Total debt | 0 | 0 | — | 14 | 35 | 41 | 26 | 48 | 22 | 27 |
| Total liabilities | — | 31 | 56 | 120 | 260 | 360 | 410 | 396 | 330 | 284 |
| Shareholders' equity | −99 | −145 | 178 | 112 | 55 | −27 | −60 | −82 | −88 | −100 |
| Non-controlling interests and other (assets − liabilities − equity) | — | 232 | — | — | 149 | 160 | 154 | 121 | 140 | 131 |
| Net debt (negative = net cash) | −54 | −26 | −124 | −70 | −147 | −63 | −72 | −37 | −41 | −46 |
Compare with peers
- Henry Schein balance sheet
- Cosmos Health Inc. balance sheet
- Cellyan Biotechnology Co., Ltd balance sheet
- Cencora balance sheet
- McKesson balance sheet
Head to head: HSIC vs YICOSM vs YIHKPD vs YICOR vs YI
More: Health Care Distributors stocks compared, Health Care sector, rankings of US companies